Kofi Karikari
About Kofi Karikari
Kofi Karikari is a Business Systems Analyst with extensive experience in the biotechnology industry. He holds a Master of Science in Computer and Information Systems and has worked at Atcc since 2016.
Work at ATCC
Kofi Karikari has been employed at ATCC as a Business Systems Analyst since 2016. In this role, he focuses on enhancing systems analysis capabilities within the organization. His work contributes to the overall efficiency and effectiveness of business operations, particularly in the biotechnology sector. Over his eight years at ATCC, he has utilized his expertise in IT strategy and business intelligence to support various projects and initiatives.
Education and Expertise
Kofi Karikari holds a Master of Science degree in Computer and Information Systems, which he obtained from the University of Maryland Global Campus between 2017 and 2020. He also earned a Bachelor of Science in Information Systems from Morgan State University from 2007 to 2011, along with a Bachelor of Arts from the same institution. Additionally, he completed an Associate of Arts degree at Baltimore City Community College. His educational background provides a solid foundation in systems analysis, with a focus on security and information assurance.
Background
Kofi Karikari has a strong background in the biotechnology industry, where he has applied his skills in IT strategy and business intelligence. His experience in this field has allowed him to enhance systems analysis capabilities, contributing to the advancement of technology solutions within the industry. His work is characterized by a focus on troubleshooting and effective systems management, particularly within Windows Server environments.
Professional Skills
Kofi Karikari possesses expertise in several key areas relevant to his role as a Business Systems Analyst. His skills include Windows Server management and troubleshooting, which are essential for effective systems analysis. His knowledge in IT strategy and business intelligence further supports his contributions to the biotechnology sector, enabling him to leverage technology for improved business outcomes.